Aro Biotherapeutics Alternatives & Competitors
12 companies similar to Aro Biotherapeutics —
Companies similar to Aro Biotherapeutics
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Nitrase Therapeutics
Pioneering Nitrase Biology and Medicines
Brisbane, United States
GenEdit
Delivering the potential of genetic medicines
South San Francisco, Unit...
Orum Therapeutics
A public biotechnology company pioneering a novel class of protein degraders.
Lexington, United States
Track all Aro Biotherapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Versameb AG
The next generation of RNA therapeutics
Basel, Switzerland
Aera Therapeutics
Enabling the next generation of transformative genetic medicines
Cambridge, United States
Generate:Biomedicines
Pioneering generative biology to create breakthrough therapeutics.
Somerville, United States
Laronde
Pioneering a completely novel translatable RNA platform - Endless RNA (eRNA)
Cambridge, United States
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Waltham, United States
Avilar Therapeutics
Pioneering the discovery and development of extracellular protein degraders.
Waltham, United States
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
About Aro Biotherapeutics
Aro Biotherapeutics, founded in 2018 and headquartered in the United States, is at the forefront of biotechnology innovation. The company specializes in developing tissue-targeted genetic medicines, leveraging its proprietary Centyrins technology. This platform is propelling the creation of a robust pipeline of therape...
Development of Centyrin-based Therapeutic Candidates, Research and Optimization of Receptor-specific Centyrins, Conjugation of Centyrins to Oligonucleotides
Patients with Genetic Disorders, Biotechnology Industry Partners, Researchers in Genetic Medicine
Genetic Medicines, Tissue-targeted Therapies, Philadelphia, Centyrins, Therapeutic Candidates, Proprietary Protein Technology, Disease Therapies, Drug Development, Biopharmaceuticals, Industry Partnerships, Disease Targeting, Genetic Medicine Innovation
B2B, Platform, B2B2B
Licensing, Product Sales, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Aro Biotherapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Aro Biotherapeutics on 12 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 21 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
